0148 REACT study: A phase III multicentre double blind randomised trial of celecoxib versus placebo in primary breast cancer patients.

Autor: von Minckwitz, G., Conrad, B., Denkert, C., Eidtmann, H., Eiermann, W., Harbeck, W., Huober, J., Jackisch, C., Lück, H., Möbus, V., Reimer, T., Rody, A., Stickeler, E.
Zdroj: Breast; Mar2009 Supplement 1, Vol. 18, pS56-S56, 1p
Databáze: Supplemental Index